UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Histone Deacetylase (HDAC) Inhibitors: A Promising Weapon to Tackle Therapy Resistance in Melanoma

International journal of molecular sciences, 2022-03, Vol.23 (7), p.3660

2022

Volltextzugriff (PDF)

Standardization of PD-L1 immunohistochemistry

Modern pathology, 2022-03, Vol.35 (3), p.294-295

2022

Volltextzugriff (PDF)

A new tool for technical standardization of the Ki67 immunohistochemical assay

Modern pathology, 2021-07, Vol.34 (7), p.1261-1270

2021

Volltextzugriff (PDF)

Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast Cancer

Clinical cancer research, 2021-11, Vol.27 (22), p.6156-6163

2021

Volltextzugriff (PDF)

Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancer

Journal for immunotherapy of cancer, 2021-04, Vol.9 (4), p.e002230

2021

Volltextzugriff (PDF)

Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC)

Oral oncology, 2023-04, Vol.139, p.106358-106358, Article 106358

2023

Volltextzugriff (PDF)

Programmed Death-Ligand 1 and Programmed Death-Ligand 2 mRNAs Measured Using Closed-System Quantitative Real-Time Polymerase Chain Reaction Are Associated With Outcome and High Negative Predictive Value in Immunotherapy-Treated NSCLC

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.1078-1085

2022

Volltextzugriff (PDF)

The Genomic Profile of Pregnancy-Associated Breast Cancer: A Systematic Review

Frontiers in oncology, 2020-09, Vol.10, p.1773-1773

2020

Volltextzugriff (PDF)

Overcoming Resistance to Temozolomide in Glioblastoma: A Scoping Review of Preclinical and Clinical Data

Life (Basel, Switzerland), 2024-06, Vol.14 (6), p.673

2024

Volltextzugriff (PDF)

High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC)

Journal for immunotherapy of cancer, 2024-06, Vol.12 (6), p.e009039

2024

Volltextzugriff (PDF)

Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer

Journal for immunotherapy of cancer, 2022-08, Vol.10 (8), p.e004757

2022

Volltextzugriff (PDF)

Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapy

Oncoimmunology, 2023-12, Vol.12 (1), p.2260618-2260618

2023

Volltextzugriff (PDF)

Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case-control study

Breast cancer research : BCR, 2021-12, Vol.23 (1), p.113-113, Article 113

2021

Volltextzugriff (PDF)

Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance

Frontiers in oncology, 2022-10, Vol.12, p.990367-990367

2022

Volltextzugriff (PDF)

A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better

Molecular cancer, 2023-11, Vol.22 (1), p.182-182, Article 182

2023

Volltextzugriff (PDF)

A new genetic variant of hereditary apolipoprotein A-I amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic options

BMC medical genetics, 2019-01, Vol.20 (1), p.23-23, Article 23

2019

Volltextzugriff (PDF)

Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms

EBioMedicine, 2022-08, Vol.82, p.104143-104143, Article 104143

2022

Volltextzugriff (PDF)

Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases

Journal for immunotherapy of cancer, 2023-08, Vol.11 (8), p.e007240

2023

Volltextzugriff (PDF)

PARP inhibitors in head and neck cancer: Molecular mechanisms, preclinical and clinical data

Oral oncology, 2021-06, Vol.117, p.105292-105292, Article 105292

2021

Volltextzugriff (PDF)

Putting the Microenvironment into the Immunotherapy Companion Diagnostic

Clinical cancer research, 2021-07, Vol.27 (14), p.3812-3814

2021

Volltextzugriff (PDF)

Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer

Laboratory investigation, 2022-10, Vol.102 (10), p.1101-1108

2022

Volltextzugriff (PDF)

Abstract P4-03-01: Budding Tumorigenesis: A novel proposed model for breast cancer tumorigenesis

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P4-P4-03-01

2022

Volltextzugriff (PDF)

Multiplex Immunohistochemistry and Immunofluorescence: A Practical Update for Pathologists

Modern pathology, 2023-07, Vol.36 (7), p.100197-100197, Article 100197

2023

Volltextzugriff (PDF)

Implications of the Hippo Pathway Dysregulation in Uterine Leiomyosarcoma

Anticancer research, 2024-08, Vol.44 (8), p.3331-3336

2024

Volltextzugriff (PDF)

Quantitative Measurement of HER2 Expression in Non–Small Cell Lung Cancer With a High-Sensitivity Assay

Modern pathology, 2024-09, Vol.37 (9), p.100556, Article 100556

2024

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(44)
Berichte
(1)

Sprache

Englisch
(45)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Humans
(24)
Oncology
(18)
Immunotherapy
(15)
Biomarkers
(9)
Tumors
(9)
Cancer
(8)
Tumor Microenvironment
(8)
Female
(7)
Patients
(7)
Proteins
(7)
Immunohistochemistry
(6)
Mutation
(6)
Pathology
(6)
Antibodies
(5)
Carcinoma, Non-Small-Cell Lung - Pathology
(5)
Immunology
(5)
Lung Neoplasms - Pathology
(5)
Programmed Cell Death 1 Receptor
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Histone Deacetylase (HDAC) Inhibitors: A Promising Weapon to Tackle Therapy Resistance in Melanoma

Standardization of PD-L1 immunohistochemistry

A new tool for technical standardization of the Ki67 immunohistochemical assay

Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast Cancer

Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancer

Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC)

Programmed Death-Ligand 1 and Programmed Death-Ligand 2 mRNAs Measured Using Closed-System Quantitative Real-Time Polymerase Chain Reaction Are Associated With Outcome and High Negative Predictive Value in Immunotherapy-Treated NSCLC

The Genomic Profile of Pregnancy-Associated Breast Cancer: A Systematic Review

Overcoming Resistance to Temozolomide in Glioblastoma: A Scoping Review of Preclinical and Clinical Data

High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC)

Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer

Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapy

Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case-control study

Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance

A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better

A new genetic variant of hereditary apolipoprotein A-I amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic options

Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms

Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases

PARP inhibitors in head and neck cancer: Molecular mechanisms, preclinical and clinical data

Putting the Microenvironment into the Immunotherapy Companion Diagnostic

Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer

Abstract P4-03-01: Budding Tumorigenesis: A novel proposed model for breast cancer tumorigenesis

Multiplex Immunohistochemistry and Immunofluorescence: A Practical Update for Pathologists

Implications of the Hippo Pathway Dysregulation in Uterine Leiomyosarcoma

Quantitative Measurement of HER2 Expression in Non–Small Cell Lung Cancer With a High-Sensitivity Assay

Suchergebnisse filtern